GCTK

GlucoTrack Inc

0.5335

Jul 17 • 05:55AM ET +0.0335 (6.70%)

Healthcare Medical Instruments & Supplies USA Nano NASD

Jul 16, 5:32 PMGCTK surges 48% after-hours on Lōkahi Therapeutics merger completion and leadership updates

Peers: LUCY NXGL BNGO CUPR RGNT FEMY RVP ZJYL HBIO MLSS

Index	-
Market Cap	3.34M
Enterprise Value	3.00M
Income	-16.89M
Sales	0.00M
Book/sh	-0.34
Cash/sh	0.63
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	15
IPO	Apr 25, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	0.85
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.85
Current Ratio	0.85
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / No

EPS (ttm)	-20.88
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	73.72% 50.71%
Sales past 3/5Y	- -
EPS Y/Y TTM	99.39%
Sales Y/Y TTM	-
EPS Q/Q	93.44%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	1.00%
Insider Trans	0.00%
Inst Own	4.33%
Inst Trans	1.48%
ROA	-241.82%
ROE	-527.20%
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	36.59%
SMA50	4.40%
SMA200	-80.94%
Trades

Shs Outstand	6.26M
Shs Float	6.20M
Short Float	8.23%
Short Ratio	0.08
Short Interest	0.51M
52W High	14.14 -96.23%
52W Low	0.29 83.52%
Volatility	23.75% 14.77%
ATR (14)	0.08
RSI (14)	61.87
Beta	0.73
Rel Volume	39.08
Avg Volume	6.33M
Volume	12,365,657

Perf Week	27.82%
Perf Month	34.38%
Perf Quarter	-28.10%
Perf Half Y	-85.54%
Perf YTD	-86.21%
Perf Year	-90.99%
Perf 3Y	-99.98%
Perf 5Y	-100.00%
Perf 10Y	-100.00%
Recom	-
Target Price	-
Prev Close	0.50
Price	0.53
Change	6.70%

Jul-16-26 04:57PM	UPDATE - Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform (GlobeNewswire) -5.48% +6.70%
Jul-15-26 11:09AM	Glucotrack Completes Lokahi Therapeutics Business Combination, Creating AI-Driven Healthcare Platform (InvestorsHub)
11:09AM	Glucotrack Completes Lkahi Therapeutics Business Combination, Creating AI-Driven Healthcare Platform (InvestorsHub)
Jul-14-26 05:40PM	Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform (GlobeNewswire) +14.13%
Jul-08-26 05:38PM	Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM (Exec Edge) +6.12%
08:00AM	Loading…
08:00AM	Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform (GlobeNewswire)
May-26-26 08:00AM	Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions (GlobeNewswire) +18.92%
May-14-26 05:27PM	Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights (GlobeNewswire)
May-07-26 03:50PM	Glucotrack Submits Blood Glucose Monitoring Technology to FDA (Exec Edge)
01:00PM	Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology (GlobeNewswire)
May-06-26 10:30AM	BC-Most Active Stocks (Associated Press) +16.92%
Apr-30-26 04:56PM	Glucotrack Shows Long-Term Accuracy of Implantable Glucose Monitor (Exec Edge) -7.26% -6.31%
09:00AM	Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology (GlobeNewswire)
Apr-29-26 10:30AM	BC-Most Active Stocks (Associated Press) +10.00%
Apr-21-26 11:59AM	Study Supports GlucoTracks Blood Glucose Monitoring Implant (Exec Edge)
08:00AM	Loading…
08:00AM	Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology (GlobeNewswire)
Mar-30-26 04:50PM	Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire) -23.57% -14.11%
Mar-27-26 09:59PM	Glucotrack to File for FDA Exemption Based on 2025 Milestones (Exec Edge) -9.16%
08:01AM	Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones (GlobeNewswire)
Mar-10-26 08:01AM	Glucotrack to Present at LSI USA '26 Medtech Innovation Summit (GlobeNewswire)
Jan-29-26 05:42PM	Glucotrack Announces 3 New Patents to Monitor Blood Glucose (Exec Edge) -33.43% -15.86%
08:01AM	Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform (GlobeNewswire)
Dec-30-25 08:00AM	Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor (GlobeNewswire) -10.85%
Nov-13-25 04:05PM	Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights (GlobeNewswire) -8.64%
Nov-03-25 04:05PM	Glucotrack, Inc. Encourages Shareholders to Vote (GlobeNewswire) -5.88%
Oct-29-25 04:05PM	Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team (GlobeNewswire) -11.64%
Oct-28-25 08:00AM	Glucotrack, Inc. Reminds Shareholders to Vote (GlobeNewswire) +9.94%
Sep-11-25 08:00AM	Glucotrack to Participate in the Q3 Virtual Investor Summit (GlobeNewswire) +5.18%
Sep-02-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +26.07%
Aug-14-25 04:05PM	Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
08:30AM	Loading…
Aug-06-25 08:30AM	Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology (GlobeNewswire)
Jul-31-25 08:30AM	Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting (GlobeNewswire)
Jul-21-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +36.71%
Jul-08-25 08:30AM	Glucotrack Announces Repurchase of Series A Warrants (GlobeNewswire)
Jun-25-25 08:30AM	Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions (GlobeNewswire) +26.25%
Jun-12-25 09:05AM	Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements (GlobeNewswire) -33.81%
Jun-04-25 08:30AM	Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions (GlobeNewswire)
May-28-25 08:30AM	Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD (GlobeNewswire)
May-20-25 08:30AM	Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development (GlobeNewswire)
May-14-25 05:10PM	Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights (GlobeNewswire)
10:23AM	Glucotrack gains HREC approval for clinical study of CBGM device (Medical Device Network)
May-13-25 08:01AM	Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor (GlobeNewswire)
Apr-16-25 08:00AM	Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas (GlobeNewswire)
Apr-03-25 08:01AM	Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor (GlobeNewswire) -6.59%
Mar-31-25 05:00PM	Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire) -14.88% +28.94%
Mar-19-25 08:01AM	Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes (GlobeNewswire) +8.90%
Feb-26-25 08:01AM	Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member (GlobeNewswire) +5.23%
Feb-05-25 11:52AM	Glucotrack Prices $3 Million Public Offering to Fund Expansion (GuruFocus.com) -12.47%
Feb-04-25 01:44PM	Glucotrack hits trial success for direct blood measuring CGM (Medical Device Network) -28.95%
12:24PM	Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering (GlobeNewswire)
08:01AM	Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor (GlobeNewswire)
Jan-30-25 08:00AM	Glucotrack Announces Reverse Stock Split (GlobeNewswire) -24.06%
Jan-29-25 09:00AM	Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer (GlobeNewswire)
Jan-21-25 08:01AM	Glucotrack Announces ISO 13485:2016 Certification (GlobeNewswire) +47.23%
Jan-15-25 08:01AM	Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs (GlobeNewswire) -35.25%
Jan-07-25 04:05PM	Glucotrack to Present at TechBio Showcase 2025 (GlobeNewswire) -10.45%
Dec-03-24 08:30AM	GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire)
Nov-14-24 04:30PM	Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt (GlobeNewswire) -14.33% -12.06%
Nov-13-24 09:00AM	Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering (GlobeNewswire) -77.06%
Oct-22-24 09:00AM	GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE (GlobeNewswire)
Oct-01-24 09:00AM	GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING (GlobeNewswire)
Sep-03-24 09:00AM	JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS (GlobeNewswire)
Aug-27-24 09:00AM	GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS (GlobeNewswire)
Aug-15-24 09:00AM	Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference (GlobeNewswire) +22.74%
Aug-05-24 09:00AM	GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE (GlobeNewswire)
Jul-31-24 04:00PM	GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) -6.25% +10.00%
Jun-20-24 08:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS (GlobeNewswire)
Jun-13-24 09:19AM	GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR (GlobeNewswire)
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE) -7.19%
Jun-10-24 10:50AM	GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE (GlobeNewswire)
Jun-05-24 08:30AM	GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire)
May-17-24 02:52PM	GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 (InvestorPlace)
May-16-24 08:30AM	GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY (GlobeNewswire)
May-15-24 04:15PM	GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT (GlobeNewswire) -10.20%
May-02-24 09:00AM	GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION (GlobeNewswire)
Apr-29-24 07:33AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +23.00%
Apr-25-24 02:18AM	Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK) (GuruFocus.com)
Apr-22-24 02:10PM	GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT (GlobeNewswire) +9.88%
Apr-16-24 08:30AM	GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING (GlobeNewswire) +24.93%
Apr-03-24 07:00AM	Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now (GlobeNewswire) +13.33%
Apr-02-24 08:30AM	GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +7.46%
07:00AM	Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now (GlobeNewswire)
Mar-12-24 09:30AM	GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY (GlobeNewswire)
Feb-27-24 08:30AM	GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +13.78%
Feb-13-24 09:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAV TO CHAIR OF THE BOARD OF DIRECTORS (GlobeNewswire) -10.79%
Feb-07-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now (GlobeNewswire) +6.28%
Feb-06-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now (GlobeNewswire)
Jan-10-24 07:00AM	Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream (GlobeNewswire)
Jan-09-24 07:00AM	Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now (GlobeNewswire)
Jan-02-24 12:33PM	GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) +8.95%
Nov-30-23 05:39PM	GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT (GlobeNewswire) +7.31% +23.40%
Nov-13-23 09:00AM	GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE (GlobeNewswire)
Oct-12-23 08:30AM	GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) -20.65%
Aug-31-23 08:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS (GlobeNewswire)
Aug-28-23 09:00AM	GLUCOTRACK ANNOUNCES NEW VP OF MARKETING (GlobeNewswire)
Jul-26-23 02:30PM	The Power Play by The Market Herald Releases New Interviews with GlucoTrack and Acceleware Discussing Their Latest News (ACCESSWIRE) -7.95%
Jul-25-23 09:00AM	GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire)
Apr-17-23 11:05AM	Aegis Capital Corp. Acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ: GCTK) (ACCESSWIRE) -7.39%
09:15AM	GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Apr-13-23 09:22AM	GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire) -49.26%

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

CEODr. Paul V. Goode Ph.D.

MSc.EEMr. Avner Gal MBA

Co-FounderMr. David Malka BA

Chief Operations OfficerMr. Vincent Wong

Chief Scientific OfficerDr. Mark Tapsak Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GCTK

GlucoTrack Inc

Upgrade your Finviz experience